Patents by Inventor Lu Zhuang

Lu Zhuang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND PHARMACEUTICAL COMBINATION FOR PREVENTING CANCER RECURRENCE
    Publication number: 20240307496
    Abstract: The present invention relates to the field of biomedicine. Disclosed herein is a method for preventing cancer recurrence, comprising i) intermittently administering an interferon-based therapeutic agent, and optionally ii) administering an additional anticancer agent, to a subject. The present invention also relates to a pharmaceutical combination for use in said method.
    Type: Application
    Filed: January 20, 2022
    Publication date: September 19, 2024
    Applicants: XIAMEN AMOYTOP BIOTECH CO., LTD., BIOSTEED GENE TRANSFORMATION TECH. CO., LTD.
    Inventors: Xiaojin LIAO, Hanzhou WU, Hongran CHU, Peijuan ZHU, Tingting ZHANG, Qingjiang XIAO, Fenghong YIN, Linying WU, Lu ZHUANG, Weidong ZHOU, Li SUN
  • INTERFERON-BASED DISEASE TREATMENT METHOD
    Publication number: 20230285509
    Abstract: The invention relates to the field of biomedicine. In particular, the present invention relates to an interferon-based method for treating a disease, comprising intermittently administering an interferon-based therapeutic agent to a subject, where the disease is for example a viral infection or a cancer.
    Type: Application
    Filed: July 22, 2020
    Publication date: September 14, 2023
    Applicants: XIAMEN AMOYTOP BIOTECH CO., LTD., BIOSTEED GENE TRANSFORMATION TECH. CO., LTD.
    Inventors: LI SUN, Weidong ZHOU, Xiaojin LIAO, Lu ZHUANG, Ruoyi HE, Ting ZHOU, Lingying ZENG, Meihua YANG, Shiyuan WANG, Jiehua ZHENG, Linzhong ZHANG
  • INTERFERON-BASED CANCER TREATMENT METHOD AND PHARMACEUTICAL COMPOSITION
    Publication number: 20230270824
    Abstract: The present invention relates to the field of biomedicine. Disclosed herein is interferon-based method and pharmaceutical combination for treating cancer. In particular, the present invention relates to an interferon-based method for treating cancer, comprising i) intermittently administering an interferon-based therapeutic agent, and ii) administering an additional anticancer agent, preferably, Gemcitabine, to a subject. The present invention also relates to a pharmaceutical combination for use in said method.
    Type: Application
    Filed: April 14, 2023
    Publication date: August 31, 2023
    Inventors: LI SUN, WEIDONG ZHOU, XIAOJIN LIAO, LU ZHUANG, RUOYI HE, TING ZHOU, LINGYING ZENG, MEIHUA YANG, SHIYUAN WANG, JIEHUA ZHENG, LINZHONG ZHANG
  • Interferon alpha-2B modified by polyethylene glycol and methods of preparation thereof
    Patent number: 8597635
    Abstract: The present invention relates to interferon-?2b modified with Y-shaped branched polyethylene glycol (PEG) at a single Lys residue and the preparation thereof. The peglated IFN-?2b can be used for the preparation of a medicament for treating a disease, e.g. viral infections such as Hepatitis C.
    Type: Grant
    Filed: September 4, 2007
    Date of Patent: December 3, 2013
    Assignee: Biosteed Gene Expression Tech. Co., Ltd.
    Inventors: Weidong Zhou, Qingjiang Xiao, Li Sun, Tiebing Wang, Fenghong Yin, Shihong Luo, Lu Zhuang, Min Liu, Tianle Xu, Yong Zhang
  • Interferon alpha-2a modified by polyethylene glycol and methods of preparation thereof
    Patent number: 8597634
    Abstract: The present invention relates to interferon (IFN)-?2a modified at a specific Lys residue with Y-shaped branched polyethylene glycol (PEG) derivative and the preparation thereof, as well as the use of the prepared IFN-?2a modified by PEG at a single amino acid residue in medicines.
    Type: Grant
    Filed: September 4, 2007
    Date of Patent: December 3, 2013
    Assignee: Biosteed Gene Expression Tech. Co., Ltd.
    Inventors: Weidong Zhou, Qingjiang Xiao, Li Sun, Tiebing Wang, Bin Liu, Song Lin, Min Liu, Fenghong Yin, Lu Zhuang, Lifang Lei
  • INTERFERON ALPHA 2B MODIFIED BY POLYETHYLENE GLYCOL, THE PREPARATION AND USE THEREOF
    Publication number: 20110158943
    Abstract: The present invention relates to interferon-?2b modified with Y-shaped branched polyethylene glycol (PEG) at a single Lys residue and the preparation thereof. The peglated IFN-?2b can be used for the preparation of a medicament for treating a disease, e.g. viral infections such as Hepatitis C.
    Type: Application
    Filed: September 4, 2007
    Publication date: June 30, 2011
    Inventors: Weidong Zhou, Qingjiang Xiao, Li Sun, Tiebing Wang, Fenghong Yin, Shihong Luo, Lu Zhuang, Min Liu, Tianle Xu, Yong Zhang
  • INTERFERON ALPHA2A MODIFIED BY POLYETHYLENE GLYCOL, THE PREPARATION AND USE THEREOF
    Publication number: 20100239532
    Abstract: The present invention relates to interferon (IFN)-?2a modified at a specific Lys residue with Y-shaped branched polyethylene glycol (PEG) derivative and the preparation thereof, as well as the use of the prepared IFN-?2a modified by PEG at a single amino acid residue in medicines.
    Type: Application
    Filed: September 4, 2007
    Publication date: September 23, 2010
    Applicant: BIOSTEED GENE EXPRESSION TECH. CO., LTD.
    Inventors: Weidong Zhou, Qingjing Xiao, Li Sun, Tlebing Wang, Bin Liu, Song Lin, Min Liu, Fenghong Yin, Lu Zhuang, Lifang Lei
  • Oval bezel headlamp
    Patent number: D723201
    Type: Grant
    Filed: October 24, 2013
    Date of Patent: February 24, 2015
    Assignee: Coast Cutlery Co.
    Inventors: Gregory David Windom, Kam Fu Choo, Lu Zhuang
  • Round bezel headlamp
    Patent number: D723202
    Type: Grant
    Filed: October 24, 2013
    Date of Patent: February 24, 2015
    Assignee: Coast Cutlery Co.
    Inventors: Gregory David Windom, Kam Fu Choo, Lu Zhuang